
Allergan Inc. (NYSE: AGN) was raised to Overweight with a $190 price target by J.P. Morgan.
A.O. Smith Corp. (NYSE: AOS) saw several hikes after the earnings report: BMO Capital Markets raised it to Outperform, Wedbush raised it to Outperform and Sterne Agee raised it to Buy.
Boston Scientific Co. (NYSE: BSX) was reiterated as Outperform and the price target was raised to $15 from $14 at RBC Capital Markets.
E*Trade Financial Corp. (NASDAQ: ETFC) was raised to Outperform at Wells Fargo.
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) was started as Buy and with a $24 price target (versus a $9.15 close) by Maxim Group.
ALSO READ: UBS Top Stocks to Buy Working for Cancer Cures
General Motors Co. (NYSE: GM) was reiterated as Buy with a $43 price target by Bank of America Merrill Lynch.
Illumina Inc. (NASDAQ: ILMN) had strong earnings and was reiterated as Buy with a $195 target at Merrill Lynch. Mizuho also reiterated its Buy rating and raised the target to $200.
Sirius XM Holdings Inc. (NASDAQ: SIRI) was maintained as Hold at Wunderlich, but the firm trimmed the price target to $3.50 from $3.80.
SunPower Corp. (NASDAQ: SPWR) was raised to Buy from Neutral with a $37 price target at Merrill Lynch.
Vitamin Shoppe Inc. (NYSE: VSI) was raised to Buy and given a $57 price target (versus a $47.89 close) at Sterne Agee.